Musely, a direct-to-consumer brand specializing in skin care, hair care, and menopause treatment, has secured $360 million in non-dilutive financing from General Catalyst. The company plans to use the capital to accelerate customer acquisition and expand its product lines without issuing new equity. This marks one of the largest debt financings in the consumer health sector this year.
The funding comes as Musely scales its operations amid rising demand for specialized personal care products. The company’s revenue grew 40% in 2025, driven by strong online sales and partnerships with retailers. General Catalyst structured the deal as debt, meaning Musely retains full ownership control while accessing growth capital.
Musely was founded in 2018 and has since built a customer base of over 2 million users. Its products include topical treatments for menopause symptoms, hair regrowth serums, and sensitive skin solutions. The company’s direct-to-consumer model allows it to bypass traditional retail markups, offering products at lower price points.
Industry analysts note that non-dilutive financing has become a preferred route for consumer brands seeking expansion capital. Last year, similar deals included a $250 million debt raise by a major supplement brand. Musely’s decision reflects broader trends in the sector, where companies prioritize growth without sacrificing equity.
The new funds will be allocated toward marketing, inventory expansion, and potential acquisitions. Musely’s CEO stated the company aims to enter new international markets within 18 months.
Source: techcrunch.com